Rare polyagglutinable erythrocytes of NOR phenotype were found to contain two unique glycosphingolipids (designated NOR1 and NOR2). These components (not detected in normal erythrocytes) were reactive with Griffonia simplicifolia isolectin IB4 (GSL-IB4) and commonly present human anti-NOR antibodies. The NOR1 component has been reported to be a globoside containing a single galactose residue linked a1,4 to the terminal N-acetylgalactosamine. Here, we report the structural studies on a second glycolipid, NOR2, and a third novel component migrating in high-performance thin-layer chromatography (HPTLC) between NOR1 and NOR2. The structures were determined by a combination of ion trap sequential mass spectrometry (MALDI-QIT-TOF) and step-wise treatment with glycosidases, followed by identification of products on HPTLC plates with lectins and mouse monoclonal anti-NOR antibody. The NOR2 component was found to be a disaccharide extension of NOR1 with the following structure: Gala1-4GalNAcb1-3Gala1-4GalNAcb1-3Gala1-4Galb1-4Glcb1-Cer. Treatment of NOR2 with a-galactosidase gave a glycolipid migrating between NOR1 and NOR2, which did not react with either GSL-IB4 or anti-NOR antibodies but did react with GalNAc-specific soybean agglutinin. This intermediate glycolipid (now designated NOR int ) was identified as a relatively abundant component of a neutral glycolipid fraction from NOR erythrocytes, suggesting its presence as a precursor to NOR2. The structure of NOR int was also confirmed by sequential mass spectrometry studies. These results indicate that polyagglutination in NOR subjects is due to unique erythrocyte glycolipids that are synthesized by sequential addition of Gala1,4 and GalNAcb1,3 to globoside.
Introduction
Erythrocytes of a rare inheritable NOR phenotype were described for the first time by Harris et al. (1982) . Agglutination of the erythrocytes by normal blood groupcompatible human sera was strongly enhanced by pretreatment of the cells with proteases and inhibited by avian and sheep hydatic cyst fluid P1 glycoprotein. A second case of NOR polyagglutination was identified in a Polish family, and the erythrocytes were found to contain two major unique neutral glycosphingolipids, designated NOR1 and NOR2. These components were detected with Griffonia simplicifolia IB4 lectin (GSL-IB4) on high-performance thin-layer chromatography plates (HPTLC) and not observed in control erythrocytes (Kusnierz-Alejska et al., 1999) . Further evidence for the involvement of NOR1 and NOR2 glycolipids in polyagglutination has been provided by staining the same glycolipids with anti-NOR antibodies isolated from human sera (Duk et al., 2001) . Studies on the NOR1 component demonstrated the structure to be an a-galactosylated globoside, Gala1-4GalNAcb1-3Gala1-4Galb1-4Glcb1-Cer (Duk et al., 2001 ). This assigned structure was consistent with the recognition of NOR1 by GSL-IB4, a lectin specific for a-galactosyl residues (Goldstein and Winter, 1999) . The structure of NOR1 was further confirmed by synthesis of Gala1-4GalNAc and Gala1-4GalNAcb1-3Gal (Westerlind et al., 2002) , and using these oligosaccharides, the specificity of anti-NOR antibodies was determined (Duk, Westerlind, et al., 2003; Duk, Kusnierz-Alejska, et al., 2005) . All natural human anti-NOR antibodies and two recently obtained mouse monoclonal anti-NOR antibodies (nor118, and nor87) reacted most strongly with the trisaccharide that represents the terminal sequence of the NOR1 glycolipid. Human anti-NOR represented two major types of subspecificity, for Gala1-4GalNAc/Galb1-3Gal or Gala1-4GalNAc, and both mouse monoclonal anti-NOR antibodies were specific for Gala1-4GalNAc.
The aim of the present study was to structurally characterize the NOR2 glycolipid and its possible biosynthetic precursor, NOR int . The results have shown NOR2 to be a disaccharide extension of the NOR1 glycolipid, with a terminally linked additional Gala1-4GalNAcb1-3 unit. Moreover, the possible precursor, GalNAc-NOR1 (designated as NOR int ), has also been identified in NOR erythrocytes.
Results

Enzymatic degradation of NOR2 glycolipid
Reactivity of NOR1 and NOR2 glycolipids with anti-NOR antibodies suggested that the terminal sequence of both glycolipids is Gala1-4GalNAcb1-3Gal. Therefore, the NOR2 sample was isolated and treated with coffee bean a-galactosidase, and part of this degalactosylated NOR2 product was treated with jack bean b-N-acetylhexosaminidase (HexNAc). The three samples of NOR2, 'sham' treated, a-galactosidase treated, and sequentially treated with both enzymes, were fractionated by HPTLC, and the glycolipids were detected on plates with an anti-NOR MAb, nor118, and soybean agglutinin (SBA) (Fig. 1 ). An untreated total neutral glycolipid fraction from NOR erythrocytes served as a reference sample. Treatment with a-galactosidase totally transformed NOR2 into glycolipid migrating between NOR1 and NOR2 (designated NOR int ), detectable with GalNAc-specific SBA and not ( Fig. 1) or weakly (Fig. 2 ) detectable with the anti-NOR antibody. This NOR int band was also detected with SBA in the untreated total neutral glycolipid fraction from NOR erythrocytes (Fig. 1) . Treatment of degalactosylated NOR2 (NOR int ) with b-N-acetylhexosaminidase gave, in turn, the total transformation of NOR int band into NOR1, detectable with the MAb, nor118. In conclusion, these results suggested that NOR2 is a NOR1 glycolipid elongated by Gala-GalNAcb moiety.
The NOR2 glycolipid is usually detected with anti-NOR antibodies as a doublet of bands: a strong lower band and a weaker upper one (Fig. 1 ). Both bands must represent glycolipids that terminate with an a-galactose residue, because both disappeared after a-galactosidase treatment, and a single band of NOR int appeared that failed to support a difference in the ceramide moiety. It was found that a-galactosidase treatment of the upper band of NOR2 did not give any glycolipid reactive with SBA or anti-NOR MAb, nor118, and the only detectable product was a globoside (Fig. 2) . Our results suggested that while a major portion of further processed NOR1 is extended by the addition of a b-GalNAc residue, a minor portion is modified by the addition of an a-Gal residue.
A new GalNAc-terminating glycolipid (NOR int ) The detection NOR int glycolipid (Fig. 1 ) raised the question whether it is also a unique component of NOR erythrocytes.
To find an answer, total neutral glycolipids from NOR (blood group A2) erythrocytes and control A1 and A2 erythrocytes were probed on the HPTLC plate with SBA. As shown in Fig. 3 , this lectin detected bands common for NOR and control erythrocytes (blood group A glycolipid and a weak band of globoside), and stained strongly an additional band, migrating between NOR1 and NOR2, but only in the NOR erythrocyte glycolipids. This latter SBA-reactive glycolipid (NOR int ) did not react with Helix pomatia agglutinin (HPA), which detected only blood group A glycolipids in control and NOR erythrocytes (Fig. 3) . Interestingly, SBA detected only the faster migrating blood group A glycolipid, whereas HPA stained strongly two major bands; an explanation of this was outside the scope of our work. Both lectins, SBA and HPA, are specific for GalNAc, but HPA reacts only with a-linked GalNAc, whereas SBA recognizes both a-and b-linked GalNAc residues (Wu et al., 2001) . In view of this, the oligosaccharide chain of NOR int is most likely terminated with b-linked GalNAc residue. This was confirmed with the finding that isolated NOR int , similarly to the degalactosylated NOR2, was digested with b-N-acetylhexosaminidase, and the product of this reaction was the NOR1 glycolipid (Fig. 4) . All these results indicated that Fig. 2 . The a-galactosidase treatment of the isolated upper band of NOR2 glycolipid. T, total neutral glycolipid fraction from NOR erythrocytes; 1 and 2, 'sham'-treated and a-galactosidase treated NOR2-upper band glycolipid, respectively. The glycolipids were detected on the HPTLC plates with anti-NOR MAb nor118, SBA and anti-Gb 4 MAb HJ6. Fig. 1 . Characterization of enzymatic degradation products of the isolated NOR2 glycolipid on the HPTLC plates. Left panel: orcinol staining; middle and right panels: detection of glycolipids with the anti-NOR MAb nor118 and SBA, respectively. Lanes A1 and NOR, total neutral glycolipid fractions from control A1 and NOR erythrocytes, respectively; 1, purified NOR2 control sample; 2, NOR2 treated with a-galactosidase; 3, NOR2, pretreated with a-galactosidase and then treated with b-N-acetylhexosaminidase. Glycolipids of NOR erythrocytes NOR int , a unique component of NOR erythrocytes, is the NOR1 glycolipid with additional b-linked GalNAc residue and is identical with the product of digestion of the NOR2 glycolipid with a-galactosidase.
Mass spectrometry analysis of NOR2 (MALDI-QIT-TOF)
In support of the enzymatic hydrolysis, the NOR2 sample was methylated and analyzed by MALDI-QIT-TOF mass spectrometry. In the spectrum, a major ion pair m/z 2226.2 (M þ Na) þ and m/z 2204.2 (M þ H) þ was observed, along with an unidentified ion m/z 2370.4 (Fig. 5a ). This latter ion failed to fit any known glycosphingolipid composition and its ion current was inadequate for it to be evaluated further. One additional ion, m/z 1566.7, was judged to be a heptasaccharide fragment formed as a consequence of a neutral loss of the ceramide moiety. MALDI sources, lacking atmosphere pressure cooling, are recognized to be more energetic, which may account for this facile neutral loss. Isolation of the most abundant ion (M þ Na) þ , resonance activation, and CID provided the MS 2 spectrum (Fig. 5b) . The major product fragment, m/z 1566.7, was 449 amu larger than that observed for the NOR1 glycan (Duk et al., 2001) , supporting the enzymatic hydrolysis studies indicating a Gal-GalNAc increment to the NOR1 nonreducing terminus. This was also supported by the fragment m/z 1760.7, a composition loss equal to GalGalNAc, consistent with the structure shown in Fig. 5c . To confirm the sequence of the reducing terminal tetrasaccharide, the glycan fragment m/z 1566.7 was isolated and analyzed by MS 3 (Fig. 6a ). All major fragments could be accounted for as rupture adjacent to HexNAc residues, which was anticipated. A single cross-ring fragment, m/z 778.6, confirmed the linkage information established earlier (Duk et al., 2001) . The structural details within the terminal tetrasaccharide were further evaluated by MS 4 analysis for the m/z 935.4 ion fragment (Fig. 6b) . As was characteristic, facile HexNAc glycosidic bond rupture (m/z 486.3) coupled with cross-ring cleavages (m/z 329.1 and 778.6) defined the 4-Olinkages in the penultimate and reducing terminal residues. Isolation of the nonreducing terminal disaccharide fragment, m/z 486, and analysis by MS 5 (Fig. 7a) showed these spectra to be identical with the Gala1-4GalNAc library standard and the same fragment observed in the NOR1 isolate. A contrast of this Gala1-4GalNAc fragment spectrum with those of the Galb1-3GalNAc and Galb1-4GlcNAc isomers (Fig. 7 , a, b, and c, respectively) provided strong evidence for the identification of ion m/z 486.3 and some differential specificity of these isomers (Fig.7, a and c) . Such analysis has provided an opportunity to build a fragment library for detailed characterization of monomer stereochemistry and linkage isomers within numerous dimers (Ashline et al., 2005; Zhang et al., 2005) . In this case, the presence of a m/z 329 fragment (marker for 4-linkage) and absence of m/z 384 (marker for 3-linkage) (Fig. 7) support the proposed 4-linkage structure. Equally informative was the MS 3 spectrum of the m/z 935.4 ion ( Fig. 6b) , showing a fragment 14 amu lower than the terminal disaccharide, m/z 486.3. This we attribute to the penultimate, or internal, Gal-GalNAc fragment (see structure in Fig. 6b ). This would be the expected disaccharide fragment (m/z 472.3, free hydroxyl on C-4) with a related cross-ring fragment at m/z 315.1, which indicates a 1-4 interresidue linkage. Thus, three cross-ring cleavage fragments, m/z 778.6, 329.1, and 315.1, confirm the internal 1-4 linkage for each Gal-GalNAc disaccharide (m/z 486.3 and 472.3). The terminal disaccharide linkage to the NOR1 moiety could not be confirmed by mass spectrometry. For NOR1 studies, a GalNAc1-3 linkage was established by finding that Gal residue is attached to globoside (Duk et al., 2001 ). The ion fragment, m/z 658.6, (Fig. 5b) , detected previously in NOR1, suggests that this sample comprises a C18 sphingosine and C24 monounsaturated fatty acid. Sample size limitations did not allow further studies on this ion.
A careful screening of the MS spectra of glycolipids eluted from the NOR2 region of TLC plates (containing the double NOR2 band) did not show the presence of any additional NOR1-elongation product with carbohydrate moiety different from that present in NOR2. Probably, the amount of an additional glycolipid giving a weak upper band of NOR2 is too small to allow its detection by MS.
Mass spectrometry analysis of NOR int
The NOR int glycolipid, isolated from neutral NOR glycolipid fraction, was methylated and analyzed by MALDI-QIT-TOF mass spectrometry. The most abundant ion of MS 1 spectrum (not shown), m/z 2021.3, was 245.2 Da higher in mass than NOR1 and 204.2 Da lower than NOR2, strongly suggesting this component to be structurally related to NOR1 and NOR2. Ion trap isolation, activation, and MS 2 analysis provided the spectrum shown in Fig. 8a . The most abundant fragment, m/z 1361.5, indicated a loss of 659.8 Da, which was equal to the ceramide moiety identified in NOR1 and NOR2 samples, indicating that the mass modification was restricted to the glycan structure only. Isolation and MS 3 analysis of this glycan, m/z 1361.5, provided the spectrum shown in Fig. 8b . Immediately apparent were the facile cleavages proximal to HexNAc residues that were identified in other NOR samples. The shared ion sequence, m/z 449, 653, 1102, and the absence of m/z 486 for a Hex-HexNAc unit positioned the modification to be a terminal HexNAc residue.
Methylation analysis of globoside and NOR int glycolipid
To establish the linkage of this terminal GalNAc to Gal in NOR int by methylation analysis, it was necessary to take into account quantitative results, because globoside already contains one C4-substituted and one C3-substituted Gal residue. Therefore, the methylated alditol acetate derivatives of globoside and NOR int (available in larger amounts than NOR2) were compared. If the linkage of the terminal GalNAc to Gal was 1-3, NOR int should contain two C3-substituted and one C4-substituted Gal residue. The methylated and hydrolyzed globoside and NOR int samples were analyzed by gas-liquid chromatography. The shown hexose regions of the chromatograms (Fig. 9) indicated that both compounds contained only C3-and C4-substituted Gal residues, and the ratio of C3-to C4-substituted Gal residue was increased in NOR int , as compared to globoside. Despite that ratios of 2,4,6-Me-Gal to 2,3,6-Me-Gal in both compounds did not match exactly the theoretical values (most likely due to small amounts of samples available for analysis), the obtained results were in favor of 1-3 linkage of terminal GalNAc to Gal in NOR int . 
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Periodate oxidation of NOR glycolipids
In looking for another micromethod that would corroborate the GalNAc-Gal linkage in the terminal part of NOR int and NOR2, we checked the effect of periodate oxidation on the glycolipids. In the sequence GalNAcb1-?Gala1-4GalNAcb1-, the disaccharide epitope (Gal-GalNAc-) recognized by monoclonal anti-NOR antibody should be resistant to periodate, only if its Gal residue is substituted at C3. Therefore, periodate oxidation followed by Smith degradation should destroy the epitopes in the NOR1 and NOR2 glycolipids and expose the epitope in the NOR int glycolipid because the oxidized/ reduced terminal GalNAc residue was removed. To appraise this protocol, the total neutral glycolipids from NOR erythrocytes were fractionated by HPTLC and blotted to the Immobilon P membrane. The membranes were successively overlaid with periodate, sodium borohydride, and sulfuric acid. The glycolipids were then detected with MAb nor118. The results were exactly as expected: the antibody detected the NOR1 and NOR2 glycolipids on the control membrane and stained only one band migrating as NOR int on the processed membrane (Fig. 10) . These results showed that the subterminal galactose residue in NOR int is resistant to exhaustive periodate oxidation, supporting a 1-3 linkage of the terminal GalNAc residue.
Discussion
This report provides evidence that NOR erythrocytes contain three unusual glycosphingolipids, which are formed by consecutive attachment of galactose and N-acetylgalactosamine residues to globoside.
NOR1: Gala1-4GalNAcb1-3Gala1-4Galb1-4Glcb1-Cer
The structure of NOR1 was elucidated previously (Duk et al., 2001 ) and that of NOR2 has now been established by MS n studies to be Hex1-4HexNAc1-?Hex1-4HexNAc1-3Hex1-4Hex1-4Hex1-Cer. The ceramide ion, m/z 658.6, suggested a C 18 sphingosine and a C 24 monounsaturated fatty acid, as found for NOR1. Inter-residue linkages within the terminal Gal-GalNAc disaccharide (NOR1) and within each of the two Hex-HexNAc residues found in NOR2 were determined by very prominent cross-ring cleavages following MS n disassembly to dimers. Adding comparable energy to smaller oligomers greatly enhances fragmentation (decreased number of oscillators for energy dissipation) providing structural details not observed in larger ions (Ashline et al. 2005) .
A combination of MS n studies with identification of enzymatic digestion products of NOR2 supplied further data. Defining the terminal hexose residue of NOR2 as aGal was based on susceptibility to a-galactosidase and reactivity of this glycolipid with GSL-IB4 and anti-NOR antibodies (both recognizing oligosaccharide chains with terminal aGal residue). The subterminal unit of NOR2 is bGalNAc, since degalactosylated NOR2 (NOR int ) reacted with SBA, specific for a-and b-linked GalNAc, and not with HPA, specific for a-linked GalNAc, and was transformed into NOR1 by b-Nacetylhexosaminidase treatment. NOR int exists in NOR erythrocytes as an intermediate compound between NOR1 and NOR2 glycolipids and was found to be absent in control erythrocyte glycolipids.
One detail that could not be established by MS n studies was the linkage position of terminal (NOR int ) or subterminal (NOR2) GalNAc residue to galactose. This problem could not be solved by NMR studies, because the amount of glycolipids required for this technique was not available. However, the 1-3 linkage was indicated by the results of periodate oxidation and supported by methylation analysis and by the reaction of the NOR2 glycolipid with human anti-NOR type 1 antibodies. These antibodies were shown to be strongly inhibited by the synthetic trisaccharide Gala1-4GalNAcb1-3Gal and very weakly by Gala1-4GalNAc and Gala1-4Gal (the latter sequence terminating the P1 antigen). These antibodies strongly react with NOR1 and NOR2 glycolipids (Duk et al., 2005) , suggesting the existence of the same terminal trisaccharide epitope in both glycolipids. Moreover, it is most likely that NOR int glycolipid is synthesized with the participation of globoside synthase, which specifically transfers the GalNAc residue to C3 of terminal aGal residue.
The most abundant glycolipids unique for NOR erythrocytes are NOR1 and NOR int , because they are distinctly stained by orcinol in total neutral glycolipid pool fractionated by HPTLC (Fig. 1) . The amount of NOR2 is much lower, it was not or hardly detected by orcinol staining, but its identification and structural studies were possible thanks to its strong reaction with GSL-IB4 and anti-NOR antibodies and high sensitivity of mass spectrometry. The NOR2 glycolipid is usually detected with anti-NOR antibodies as a doublet of bands, a strong lower band and a weaker upper one (Fig. 1) . Transformation of this minor glycolipid to globoside by a-galactosidase treatment suggested that it is the globoside elongated with at least two aGal residues. However, the amount of this additional glycolipid was too small to allow its detection by MS.
Identification of Polish case of polyagglutination as NOR (originally reported by Harris et al. in 1982) was initially based on serological properties of erythrocytes, including a weak inhibition of anti-NOR antibodies by P1 glycoprotein. We have recently found that erythrocytes from the original American NOR-positive blood donor contain the same unique glycolipids as those identified in our NOR case. In both samples, the patterns of glycolipid staining on HPTLC plates with GSL-IB4, anti-NOR MAb nor118, and SBA were 
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identical, including the double NOR2 band detected by the antibody (Duk et al., 2006) .
To the best of our knowledge, the Gala1-4GalNAc sequence has not been reported in human and animal glycoconjugates, except in one of 25 oligosaccharide chains identified in amphibian egg jelly coat mucin (Mourad et al., 2001 ). This sequence is not common in bacteria either; it was reported only in the repeating units of lipopolysaccharide Ospecific chains of two Proteus strains (Perepelov et al., 1999; Vinogradov et al., 1989 ). An enzyme transferring an a-galactose residue to the C4 position of GalNAc is unknown. Such transferase (GalT NOR ) would be a key enzyme responsible for biosynthesis of NOR-related glycolipids. It seems to act in concert with normal b1,3-N-acetylgalactosamine transferase (Gb 4 synthase), to form several elongated forms of globoside. The GalT NOR may be the product of mutated gene encoding an existing transferase, or is a new enzyme not expressed or inactive in normal phenotypes. Further studies on the genetic background underlying the NOR phenotype are necessary to solve this problem.
Materials and methods
Erythrocytes
Erythrocytes of a healthy NOR-positive donor (TS) were serologically typed as A2, P1 (2). The control blood samples were supplied by the Regional Center of Blood Transfusion in Wroclaw.
Lectins and antibodies
Lectins, Griffonia simplicifolia IB4 isolectin (GSL-IB4), soybean agglutinin (SBA), and Helix pomatia agglutinin (HPA), purchased from Sigma, St. Louis, MO, were biotinylated as described previously (Duk et al., 1994) . Murine monoclonal anti-Gb 4 (IgM) antibody HJ6 (Madassery et al., 1991) was kindly provided by Dr. M.H. Nahm (Rochester, NY). Monoclonal anti-NOR antibody, nor118 (IgG1), specific for Gala1-4GalNAc, was obtained by immunization of mice with the conjugate of Gala1-4GalNAcb1-3Gal with human serum albumin, as described elsewhere (Duk et al., 2005) .
Extraction and purification of glycosphingolipids Isolation and fractionation of glycolipids were performed using the standard procedures described in detail in previous papers (Kusnierz-Alejska et al., 1999; Duk et al., 2001) . Briefly, glycolipids were extracted from lyophilized membranes of NOR and control erythrocytes with chloroform/ methanol; neutral glycolipids were separated from phospholipids and gangliosides, additionally purified in peracetylated form, de-O-acetylated, and desalted. To isolate individual glycolipids, neutral glycolipids from NOR erythrocytes were fractionated on the Kieselgel H type 60 (Merck, Darmstadt, Germany) column. Fractions were analyzed by HPTLC with the use of GSL-IB4 (NOR1 and NOR2) or SBA (NOR int ) and those containing the required glycolipid were pooled. Further purification of glycolipids from the column fractions was achieved by repeated preparative HPTLC and elution from the respective regions of the plate, as described by Duk et al. 2001 ).
Enzymatic degradation
The glycolipid preparations were treated with coffee bean a-galactosidase (0.4 U in a total volume of 700 ml, 72 h at 37 8 C) or with jack bean b-N-acetylhexosaminidase (2 U in a total volume of 150 ml, 65 h at 37 8 C), both from Sigma. The NOR2 glycolipid sample was treated consecutively with both enzymes; after treatment with a-galactosidase, the glycolipids were isolated from the reaction mixture and a half of the portion was treated with b-N-acetylhexosaminidase. Other details concerning the conditions of enzymatic treatment and processing the samples before and after treatment were based on the procedure reported by Ostrander et al. 1988 ) and described in detail by Duk et al. 2001 ). The control glycolipid samples were submitted to the same procedures, omitting enzymes.
HPTLC lectin and antibody assays
The glycolipid samples solubilized in chloroform/methanol (2 : 1, v/v) were applied to HPTLC plates (Kieselgel 60, Merck) and developed with chloroform/methanol/water (55 : 45 : 10, v/v/v). The dried plates were immersed in 0.05% polyisobutylmethacrylate (Aldrich, Steinheim, Germany) in hexane for 1 min, dried again, sprayed with TBS (0.05 M Tris buffer, 0,15 M NaCl, pH 7.4), and immersed in 5% human serum albumin (HSA) for 1 h (Magnani et al., 1982) . The plates were overlaid successively with (i) biotinylated lectin solution (5 mg/ml) in TBS/0.05% Tween 20/1% HSA (TBS-T/HSA) for 1 h, (ii) ExtrAvidinalkaline phosphatase conjugate (Sigma) diluted with TBS-T/ HSA for 1 h, and (iii) a substrate (nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate, from Sigma) solution. The immunostaining with monoclonal antibodies was done similarly, but instead of biotinylated lectins, the plates were overlaid with the nor118 antibody (1.5 h) or with the HJ6 antibody (overnight in refrigerator) and then with biotinylated goat antibodies against mouse Ig (Dako, Glostrup, Denmark) for 1 h. All incubations, if not stated otherwise, were done at room temperature.
Smith degradation of glycolipids on the blots
The procedure could not be performed directly on the HPTLC plates, because the silica layer was mechanically destroyed by NaBH 4 or by acid treatment. Therefore, the glycolipids fractionated on the HPTLC plates were transferred to PVDF membranes (Immobilon P, Millipore, Carrigtwohill, Ireland) using the 'ironing' method (Taki and Ishikawa, 1997) . The dried membranes were immersed for 1 -2 seconds in 96% ethanol, washed with water, and overlaid successively with (i) 0.05 M sodium periodate in 0.05 M acetate buffer pH 4.5 for 48 h in refrigerator, (ii) 0.15 M NaBH 4 in 0.2 M borate buffer pH 8.0 for 3 h at room temperature, and (iii) 0.025 M H 2 SO 4 for 1 h at 80 8 C. After each incubation, the membranes were washed with water. The control membranes, after treatment with ethanol, were incubated in acetate buffer without periodate. The membranes were then incubated (overnight in refrigerator) in 5% bovine serum albumin in TBS, washed with TBS, and glycolipids were detected with the MAb nor118, using the same procedure as described for HPTLC plates.
Glycolipid methylation
Glycolipid methylation for MS n studies was achieved by dissolving samples in a suspension of NaOH/DMSO prepared by vortex mixing DMSO and powdered sodium hydroxide (Ciucanu and Kerek, 1984) . After 1 h at room temperature, 50 mg of methyl iodide was added, and the suspension set for 1 h at room temperature with occasional vortexing. The methylated product was back extracted by adding 1 ml of chloroform, and the suspensions were washed four times with 2 -3 ml of 30% acetic acid (Reinhold et al., 1996) . Methylated samples were dried following chloroform extraction and stored at 220 8 C. The samples were re-dissolved to a concentration of 10 mM in a 1 mM solution of sodium acetate in 70 : 30 methanol/water just prior to analysis.
Glycolipid methylation for gas-liquid chromatography was done by a similar procedure (Gunnarsson, 1987) . Briefly, a dried sample was dissolved in 0.2 ml of dry DMSO by stirring for 30 min. A portion of 12 -14 mg of finely powdered NaOH was added, followed by 30 ml of methyl iodide, and the suspension was stirred for 2 h. It was neutralized with 1 M acetic acid and diluted with 0.2 ml water. Finally, permethylated glycolipids were extracted in chloroform, washed with water and evaporated.
MALDI-QIT-TOF mass spectrometry
The methylated samples were analyzed by MALDI-QIT-TOF (Axima-IT, Shimadzu Biotech, Kratos Analytical, Ltd., Manchester, UK). This ion trap MS was configured with MALDI for high throughput analysis and coupled with a TOF analyzer for improved mass resolution. The source was decoupled from the analyzer and transparent to laser irradiation effects that are nearly at a perpendicular angle to the sample stage. The 384 spotting plates were irradiated with an LSI N2 laser (337 nm, $3 ns pulse width, 300mJ max.) and argon was used in ion trap CID studies. The methylated glycolipids were resuspended in methanol and mixed with 5 ml DHB (2,5-dihydroxybenzoic acid, gentisic acid) matrix and spotted (0.5 -1 ml) on the target plate and allowed to dry. Laser power was set to 70 mW, mass range 50-5000 atm, using 10 shots per profile, 100 profiles per sample in reflectron mode.
Gas-liquid chromatography
The sample of methylated glycolipids was hydrolyzed in 4 M trifluoroacetic acid for 4 h at 100 8C and derivatized into alditol acetates. Partially methylated alditol acetates were analyzed in a Hewlett-Packard 5890 gas chromatograph, equipped with a mass selective detector 5971A and HP-1 capillary column (0.2 mm Â 12 m). A temperature gradient of 150-230 8C (8 8C/min) was used. Quantification of methylated sugar derivatives was based on the total ion current (TIC). The peaks were identified by mass spectra and elution time.
